Search

Your search keyword '"Bendik Lund"' showing total 52 results

Search Constraints

Start Over You searched for: Author "Bendik Lund" Remove constraint Author: "Bendik Lund"
52 results on '"Bendik Lund"'

Search Results

1. Intelligence and executive function are associated with age at insult, time post-insult, and disability following chronic pediatric acquired brain injury

2. The Norwegian childhood cancer biobank

3. Phosphatase of regenerating liver-3 (PRL-3) is overexpressed in classical Hodgkin lymphoma and promotes survival and migration

4. Supplementary figure 2 from Hematopoietic Stem Cell Transplantation Positively Affects the Natural History of Cancer in Nijmegen Breakage Syndrome

5. Supplementary figure 1 from Hematopoietic Stem Cell Transplantation Positively Affects the Natural History of Cancer in Nijmegen Breakage Syndrome

6. Supplementary Figure 3 from Hematopoietic Stem Cell Transplantation Positively Affects the Natural History of Cancer in Nijmegen Breakage Syndrome

7. Supplementary Data legend from Hematopoietic Stem Cell Transplantation Positively Affects the Natural History of Cancer in Nijmegen Breakage Syndrome

8. Supplementary Table 1 from Hematopoietic Stem Cell Transplantation Positively Affects the Natural History of Cancer in Nijmegen Breakage Syndrome

9. DNA-thioguanine concentration and relapse risk in children and young adults with acute lymphoblastic leukemia: an IPD meta-analysis

10. No association between relapse hazard and thiopurine methyltransferase geno- or phenotypes in non-high risk acute lymphoblastic leukemia: a NOPHO ALL2008 sub-study

11. Value of flow cytometry for MRD-based relapse prediction in B-cell precursor ALL in a multicenter setting

12. TPMT polymorphisms and minimal residual disease after 6-mercaptopurine post-remission consolidation therapy of childhood acute lymphoblastic leukaemia

13. Effects of germline DHFR and FPGS variants on methotrexate metabolism and relapse of leukemia

14. Characteristics of white blood cell count in acute lymphoblastic leukemia: A COST LEGEND phenotype–genotype study

15. Asparaginase-Associated Pancreatitis in Acute Lymphoblastic Leukemia: Results From the NOPHO ALL2008 Treatment of Patients 1-45 Years of Age

16. Bereaved parents’ quality of life: resilience and professional support

17. Relapse risk following truncation of PEG-asparaginase in childhood acute lymphoblastic leukemia

18. Hematopoietic Stem Cell Transplantation Positively Affects the Natural History of Cancer in Nijmegen Breakage Syndrome

19. The Norwegian childhood cancer biobank

20. Low burden of minimal residual disease prior to transplantation in children with very high risk acute lymphoblastic leukaemia: The NOPHO ALL2008 experience

21. Health-related quality of life and psychological distress in young adult survivors of childhood cancer and their association with treatment, education, and demographic factors

22. Impact of body mass index on relapse in children with acute lymphoblastic leukemia treated according to Nordic treatment protocols

23. Relapse following truncation of Asparaginase in NOPHO ALL2008

24. Intermittent Versus Continuous PEG-Asparaginase to Reduce Asparaginase-Associated Toxicities: A NOPHO ALL2008 Randomized Study

25. Genetic predisposition to PEG-asparaginase hypersensitivity in children treated according to NOPHO ALL2008

26. Minimal residual disease quantification by flow cytometry provides reliable risk stratification in T-cell acute lymphoblastic leukemia

27. Asparaginase-Associated Pancreatitis in ALL: Results from the NOPHO ALL2008 Treatment of Patients 1-45 Years

28. NT5C2 germline variants alter thiopurine metabolism and are associated with acquired NT5C2 relapse mutations in childhood acute lymphoblastic leukaemia

29. Phosphatase of regenerating liver-3 (PRL-3) is overexpressed in classical Hodgkin lymphoma and promotes survival and migration

30. Intermittent Versus Continuous Asparaginase to Reduce Asparaginase-Associated Toxicities: A NOHPO ALL2008 Randomized Study

31. Individualized 6-mercaptopurine increments in consolidation treatment of childhood acute lymphoblastic leukemia:A NOPHO randomized controlled trial

32. Phosphatase of regenerating liver-3 is expressed in acute lymphoblastic leukemia and mediates leukemic cell adhesion, migration and drug resistance

33. Value of Flow Cytometry for MRD-Based Relapse Prediction in B-Cell Precursor Acute Lymphoblastic Leukemia in a Multi-Center Setting

34. Usability in video game editors

35. DNA-thioguanine nucleotide concentration and relapse-free survival during maintenance therapy of childhood acute lymphoblastic leukaemia (NOPHO ALL2008): a prospective substudy of a phase 3 trial

36. Asparaginase-associated pancreatitis: a study on phenotype and genotype in the NOPHO ALL2008 protocol

37. Pneumocystis jiroveci pneumonia prophylaxis during maintenance therapy influences methotrexate/6-mercaptopurine dosing but not event-free survival for childhood acute lymphoblastic leukemia

38. Risk factors for treatment related mortality in childhood acute lymphoblastic leukaemia

39. Febrile neutropenia in children with cancer: A retrospective Norwegian multicentre study of clinical and microbiological outcome

40. Archival bone marrow samples: suitable for multiple biomarker analysis

41. Host genome variations and risk of infections during induction treatment for childhood acute lymphoblastic leukaemia

42. Abstract 198: The phosphatase PRL-3 is expressed in primary B-ALL cells and is important for adhesion and migration

43. Pneumocystis jiroveci pneumonia prophylaxis during maintenance therapy influences methotrexate/6-mercaptopurine dosing but not event-free survival for childhood acute lymphoblastic leukemia

45. Risk factors for treatment related mortality in childhood acute lymphoblastic leukaemia

46. Spectrum of clinical presentations in familial hemophagocytic lymphohistiocytosis type 5 patients with mutations in STXBP2

47. WT1 gene expression in children with Down syndrome and transient myeloproliferative disorder

48. Flow Cytometric Leukemic Blasts Detection in Cerebrospinal Fluid of Children with Acute Lymphoblastic Leukemia

50. Host Genomic Variants and Risk of Infections During Induction Treatment in Childhood Acute Lymphoblastic Leukemia

Catalog

Books, media, physical & digital resources